These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 24825901)

  • 1. Stages and conformations of the Tau repeat domain during aggregation and its effect on neuronal toxicity.
    Kumar S; Tepper K; Kaniyappan S; Biernat J; Wegmann S; Mandelkow EM; Müller DJ; Mandelkow E
    J Biol Chem; 2014 Jul; 289(29):20318-32. PubMed ID: 24825901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional networks are impaired by elevated tau-protein but reversible in a regulatable Alzheimer's disease mouse model.
    Green C; Sydow A; Vogel S; Anglada-Huguet M; Wiedermann D; Mandelkow E; Mandelkow EM; Hoehn M
    Mol Neurodegener; 2019 Mar; 14(1):13. PubMed ID: 30917861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular low-n oligomers of tau cause selective synaptotoxicity without affecting cell viability.
    Kaniyappan S; Chandupatla RR; Mandelkow EM; Mandelkow E
    Alzheimers Dement; 2017 Nov; 13(11):1270-1291. PubMed ID: 28528849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-aggregant tau mutant promotes neurogenesis.
    Joseph M; Anglada-Huguet M; Paesler K; Mandelkow E; Mandelkow EM
    Mol Neurodegener; 2017 Dec; 12(1):88. PubMed ID: 29202785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducible expression of Tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugs.
    Khlistunova I; Biernat J; Wang Y; Pickhardt M; von Bergen M; Gazova Z; Mandelkow E; Mandelkow EM
    J Biol Chem; 2006 Jan; 281(2):1205-14. PubMed ID: 16246844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model.
    Wang YP; Biernat J; Pickhardt M; Mandelkow E; Mandelkow EM
    Proc Natl Acad Sci U S A; 2007 Jun; 104(24):10252-7. PubMed ID: 17535890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competing interactions stabilize pro- and anti-aggregant conformations of human Tau.
    Wegmann S; Schöler J; Bippes CA; Mandelkow E; Muller DJ
    J Biol Chem; 2011 Jun; 286(23):20512-24. PubMed ID: 21498513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatable transgenic mouse models of Alzheimer disease: onset, reversibility and spreading of Tau pathology.
    Hochgräfe K; Sydow A; Mandelkow EM
    FEBS J; 2013 Sep; 280(18):4371-81. PubMed ID: 23517246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system.
    Tackenberg C; Kulic L; Nitsch RM
    PLoS One; 2020; 15(9):e0239584. PubMed ID: 32966331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tauopathies and tau oligomers.
    Takashima A
    J Alzheimers Dis; 2013; 37(3):565-8. PubMed ID: 23948895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy.
    Mocanu MM; Nissen A; Eckermann K; Khlistunova I; Biernat J; Drexler D; Petrova O; Schönig K; Bujard H; Mandelkow E; Zhou L; Rune G; Mandelkow EM
    J Neurosci; 2008 Jan; 28(3):737-48. PubMed ID: 18199773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligomer formation of tau protein hyperphosphorylated in cells.
    Tepper K; Biernat J; Kumar S; Wegmann S; Timm T; Hübschmann S; Redecke L; Mandelkow EM; Müller DJ; Mandelkow E
    J Biol Chem; 2014 Dec; 289(49):34389-407. PubMed ID: 25339173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous Monitoring of Tau-Induced Neurotoxicity in Patient-Derived iPSC-Neurons.
    Oakley DH; Klickstein N; Commins C; Chung M; Dujardin S; Bennett RE; Hyman BT; Frosch MP
    J Neurosci; 2021 May; 41(19):4335-4348. PubMed ID: 33893219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of stable tau oligomers for cellular and biochemical studies.
    Karikari TK; Nagel DA; Grainger A; Clarke-Bland C; Hill EJ; Moffat KG
    Anal Biochem; 2019 Feb; 566():67-74. PubMed ID: 30315761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and Characterization of Low-n Tau Oligomers.
    Kaniyappan S; Chandupatla RR; Mandelkow E
    Methods Mol Biol; 2018; 1779():99-111. PubMed ID: 29886530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventive methylene blue treatment preserves cognition in mice expressing full-length pro-aggregant human Tau.
    Hochgräfe K; Sydow A; Matenia D; Cadinu D; Könen S; Petrova O; Pickhardt M; Goll P; Morellini F; Mandelkow E; Mandelkow EM
    Acta Neuropathol Commun; 2015 May; 3():25. PubMed ID: 25958115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effects of amyloid-beta and wild-type human tau on dendritic spine loss in a floxed double transgenic model of Alzheimer's disease.
    Chabrier MA; Cheng D; Castello NA; Green KN; LaFerla FM
    Neurobiol Dis; 2014 Apr; 64():107-17. PubMed ID: 24440055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau-induced defects in synaptic plasticity, learning, and memory are reversible in transgenic mice after switching off the toxic Tau mutant.
    Sydow A; Van der Jeugd A; Zheng F; Ahmed T; Balschun D; Petrova O; Drexler D; Zhou L; Rune G; Mandelkow E; D'Hooge R; Alzheimer C; Mandelkow EM
    J Neurosci; 2011 Feb; 31(7):2511-25. PubMed ID: 21325519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The beta-propensity of Tau determines aggregation and synaptic loss in inducible mouse models of tauopathy.
    Eckermann K; Mocanu MM; Khlistunova I; Biernat J; Nissen A; Hofmann A; Schönig K; Bujard H; Haemisch A; Mandelkow E; Zhou L; Rune G; Mandelkow EM
    J Biol Chem; 2007 Oct; 282(43):31755-65. PubMed ID: 17716969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resonance Raman spectroscopic measurements delineate the structural changes that occur during tau fibril formation.
    Ramachandran G; Milán-Garcés EA; Udgaonkar JB; Puranik M
    Biochemistry; 2014 Oct; 53(41):6550-65. PubMed ID: 25284680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.